标题
The potential of polygenic scores to improve cost and efficiency of clinical trials
作者
关键词
-
出版物
Nature Communications
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-25
DOI
10.1038/s41467-022-30675-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease
- (2021) Ganqiang Liu et al. NATURE GENETICS
- Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
- (2020) Akl C. Fahed et al. Nature Communications
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transethnic Transferability of a Genome-wide Polygenic Score for Coronary Artery Disease
- (2020) Akl C. Fahed et al. Circulation-Genomic and Precision Medicine
- BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
- (2019) Andrew Lee et al. GENETICS IN MEDICINE
- Clinical use of current polygenic risk scores may exacerbate health disparities
- (2019) Alicia R. Martin et al. NATURE GENETICS
- Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial
- (2019) Nicholas A. Marston et al. CIRCULATION
- Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial
- (2019) Amy Damask et al. CIRCULATION
- Realizing the Dream of Molecularly Targeted Therapies for Cystic Fibrosis
- (2019) Francis S. Collins NEW ENGLAND JOURNAL OF MEDICINE
- The personal and clinical utility of polygenic risk scores
- (2018) Ali Torkamani et al. NATURE REVIEWS GENETICS
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits
- (2018) Yan Zhang et al. NATURE GENETICS
- Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
- (2018) Amit V. Khera et al. NATURE GENETICS
- Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016
- (2018) Thomas J. Moore et al. JAMA Internal Medicine
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stop Alzheimer’s before it starts
- (2017) Eric McDade et al. NATURE
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Development Challenges for Small Biopharmaceutical Companies
- (2017) Richard A. Moscicki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
- (2016) Marc S. Sabatine et al. AMERICAN HEART JOURNAL
- Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
- (2015) Jessica L Mega et al. LANCET
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started